InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Westlake BioPartners Opportunity Fund I, L.P.. Insider active across 1 company, notably Kyverna Therapeutics, Inc.. Aggregated, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €852k. Activity tracked since 18 December 2025. The latest transaction was filed on 18 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration